GlassScriptPhysician profile
Jeffrey A Klem
NPI 1366448573
$6,081.70
in general payments reported to CMS, 2019-2025
26 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $98.60 · 2021: $24.95 · 2022: $17.37 · 2023: $3,857 · 2024: $452 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,551 · Travel and Lodging: $2,368 · Education: $27.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,550.73 |
| Travel and Lodging | $2,368.48 |
| Education | $27.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,154.44 | 2023-2024 | Ellipsys Vascular Access System, Intellis Adaptivestim, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $996.79 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $197.29 | 2023 | |
| Shockwave Medical, INC | $182.45 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $171.12 | 2020-2023 | Repatha |
| Actelion Pharmaceuticals US, INC. | $158.25 | 2024-2025 | Opsumit, Uptravi |
| Inspire Medical Systems, INC. | $152.06 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $137.10 | 2023 | Xarelto |
| Biotronik INC. | $130.21 | 2023 | Biomonitor, Amvia Edge, Renamic Neo |
| Genzyme Corporation | $117.02 | 2024 | |
| Angiodynamics, INC. | $103.61 | 2023-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.83 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $84.35 | 2024-2025 | Verquvo |
| Cordis US Corp. | $81.91 | 2023 | Mynxgrip, Zephyr |
| Kestra Medical Technology Services, INC. | $76.46 | 2025 | Assure Wcd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $50.09 | 2019-2025 | Wainua |
| Scpharmaceuticals INC. | $32.25 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $25.40 | 2025 | Rotarexs 6 F X 135 Cm |
| Recor Medical INC | $24.06 | 2025 | Paradise Ultrasound Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $18.94 | 2025 | Camzyos |
| Medtronic Vascular, INC. | $18.20 | 2019 | |
| Terumo Medical Corporation | $17.06 | 2024 | Angio-Seal, Navicross |
| Currax Pharmaceuticals LLC | $16.47 | 2025 | Contrave |
| United Therapeutics Corporation | $16.23 | 2023 | Tyvaso |
| Genentech USA, INC. | $13.63 | 2019 | |
| Foundation Fusion Solutions, LLC | $12.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Klem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.